Control peptide for L-JNKI. For more details see L-JNKI1 (Prod.No. BML-EI354).
Product Details
| Alternative Name: | JNK Inhibitor 1 (L-stereoisomer) control peptide (FITC conjugate) |
| |
| Sequence: | FITC-β-A-RKKRRQRRRA-amide |
| |
| Formula: | C80H128N34O17S |
| |
| MW: | 1870.2 |
| |
| Concentration: | 1mM |
| |
| Formulation: | Liquid. In sterile PBS. |
| |
| Purity: | ≥90% (HPLC) |
| |
| Shipping: | Blue Ice |
| |
| Long Term Storage: | -20°C |
| |
| Handling: | Keep on ice at all times. Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Hyperosmolarity and CD95L trigger CD95/EGF receptor association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation: R. Reinehr, et al.; FASEB J.
17, 731 (2003),
Abstract;
Full Text
Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death: C. Bonny, et al.; Diabetes
50, 77 (2001),
Abstract;
Full Text
Related Products
